Eliquis (apixaban) prior authorization denied appeal
DOAC anticoagulant
Typical PA criteria
- Atrial fibrillation, VTE treatment, or VTE prophylaxis
- Step therapy in some plans
Why your PA was denied
- Warfarin not trialed
- Non-formulary
Evidence that overturns the denial
- ✓Diagnosis with CHA2DS2-VASc score
- ✓INR instability or bleeding history on warfarin
Step therapy with warfarin is the most common driver; document why warfarin is unsuitable.
Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.
FAQ
Why was my Eliquis (apixaban) prior authorization denied?+
The most common reasons are: Warfarin not trialed; Non-formulary. Your denial letter names the specific criteria you did not meet.
How do I appeal a Eliquis (apixaban) denial?+
File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.
What evidence overturns a Eliquis (apixaban) denial?+
Diagnosis with CHA2DS2-VASc score; INR instability or bleeding history on warfarin.
What if the plan excludes Eliquis (apixaban) entirely?+
Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.
Other drugs
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
- Ozempic (semaglutide)
- Mounjaro (tirzepatide)
- Saxenda (liraglutide)